However, paeoniflorin attenuates LPS-induced learning and memory deficits through the downregulation of BACE, APP, PS1, and PS2 in the brain, suggesting that paeoniflorin could be a promising agent against neurobehavioral impairment for AD. Here, APP is linked to Alzheimer disease.